Status:
COMPLETED
Prenatal Diagnosis of the Fetal Esophageal or Intestinal Atresia
Lead Sponsor:
Poitiers University Hospital
Conditions:
Antenatal Management of the Fetal Gastrointestinal Atresia
Eligibility:
All Genders
18-50 years
Brief Summary
Aim- to investigate how prenatal diagnosis of fetal esophageal or intestinal atresia impacts obstetric and neonatal outcomes. Methods- This was a retrospective cohort study at a single center. The st...
Detailed Description
Aim- to investigate how prenatal diagnosis of fetal esophageal or intestinal atresia impacts obstetric and neonatal outcomes. Methods- This was a retrospective cohort study at a single center. The st...
Eligibility Criteria
Inclusion
- all pregnancies affected by fetal esophageal, duodenal or intestinal atresia referred to our prenatal diagnosis unit
- all newborns managed for such atresia in our unit of pediatric surgery
Exclusion
- termination of pregnancy,
- stillbirth,
- the false positive cases
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 7 2022
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT05362604
Start Date
April 1 2021
End Date
February 7 2022
Last Update
May 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire de Poitiers
Poitiers, France, 86000